Role of Structural and Conformational Diversity for Machine Learning Potentials
Authors:
Nikhil Shenoy,
Prudencio Tossou,
Emmanuel Noutahi,
Hadrien Mary,
Dominique Beaini,
Jiarui Ding
Abstract:
In the field of Machine Learning Interatomic Potentials (MLIPs), understanding the intricate relationship between data biases, specifically conformational and structural diversity, and model generalization is critical in improving the quality of Quantum Mechanics (QM) data generation efforts. We investigate these dynamics through two distinct experiments: a fixed budget one, where the dataset size…
▽ More
In the field of Machine Learning Interatomic Potentials (MLIPs), understanding the intricate relationship between data biases, specifically conformational and structural diversity, and model generalization is critical in improving the quality of Quantum Mechanics (QM) data generation efforts. We investigate these dynamics through two distinct experiments: a fixed budget one, where the dataset size remains constant, and a fixed molecular set one, which focuses on fixed structural diversity while varying conformational diversity. Our results reveal nuanced patterns in generalization metrics. Notably, for optimal structural and conformational generalization, a careful balance between structural and conformational diversity is required, but existing QM datasets do not meet that trade-off. Additionally, our results highlight the limitation of the MLIP models at generalizing beyond their training distribution, emphasizing the importance of defining applicability domain during model deployment. These findings provide valuable insights and guidelines for QM data generation efforts.
△ Less
Submitted 30 October, 2023;
originally announced November 2023.
Molecular Design in Synthetically Accessible Chemical Space via Deep Reinforcement Learning
Authors:
Julien Horwood,
Emmanuel Noutahi
Abstract:
The fundamental goal of generative drug design is to propose optimized molecules that meet predefined activity, selectivity, and pharmacokinetic criteria. Despite recent progress, we argue that existing generative methods are limited in their ability to favourably shift the distributions of molecular properties during optimization. We instead propose a novel Reinforcement Learning framework for mo…
▽ More
The fundamental goal of generative drug design is to propose optimized molecules that meet predefined activity, selectivity, and pharmacokinetic criteria. Despite recent progress, we argue that existing generative methods are limited in their ability to favourably shift the distributions of molecular properties during optimization. We instead propose a novel Reinforcement Learning framework for molecular design in which an agent learns to directly optimize through a space of synthetically-accessible drug-like molecules. This becomes possible by defining transitions in our Markov Decision Process as chemical reactions, and allows us to leverage synthetic routes as an inductive bias. We validate our method by demonstrating that it outperforms existing state-of the art approaches in the optimization of pharmacologically-relevant objectives, while results on multi-objective optimization tasks suggest increased scalability to realistic pharmaceutical design problems.
△ Less
Submitted 16 October, 2020; v1 submitted 29 April, 2020;
originally announced April 2020.
